Sermorelin dosage by bodyweight
Reference dose ranges scaled across bodyweight bands, anchored to the most-cited research dose (200 mcg @ 75 kg). Educational only, never a recommendation.
| Bodyweight band | Reference dose range | At U-100 (1 mg/mL) | Vol. on U-100 (5 mg / 2 mL) | 5× t½ elapsed |
|---|---|---|---|---|
| <60 kg / <132 lb | 125–169 mcg | 0.13–0.17 mL | 5–7 units0.05–0.07 mL | 1.0 h |
| 60–75 kg / 132–165 lb | 153–207 mcg | 0.15–0.21 mL | 6–8 units0.06–0.08 mL | 1.0 h |
| 75–90 kg / 165–198 lb | 187–253 mcg | 0.19–0.25 mL | 8–10 units0.07–0.10 mL | 1.0 h |
| 90–105 kg / 198–231 lb | 221–299 mcg | 0.22–0.30 mL | 9–12 units0.09–0.12 mL | 1.0 h |
| >105 kg / >231 lb | 255–345 mcg | 0.26–0.34 mL | 10–14 units0.10–0.14 mL | 1.0 h |
Volume column assumes a standard 5 mg vial reconstituted with 2 mL bacteriostatic water (concentration 2.5 mg/mL); insulin units shown for a U-100 syringe. Five half-lives is the conventional washout window where ~3% of peak plasma remains, a useful "next dose due" anchor for Sermorelin (t½ 12 min).
Sermorelin by goal
Read Sermorelin's profile and dosing through a specific research-goal lens.
Dose & PK references
Selected from the Sermorelin bibliography for relevance to dosing and pharmacokinetics.
- Analysis of growth hormone releasing hormone and its analogs in urine using nano liquid chromatography
- Sermorelin: a better approach to management of adult-onset growth hormone insufficiency?
- Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency
Educational use only
This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.